SpringerLink
Log in

The Endocannabinoid System in the Cochlear Nucleus and Its Implications for Tinnitus Treatment

  • Chapter
Textbook of Tinnitus

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
GBP 19.95
Price includes VAT (United Kingdom)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
GBP 143.50
Price includes VAT (United Kingdom)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
GBP 179.99
Price includes VAT (United Kingdom)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

2-AG:

2-Arachidonylglycerol

ACPA:

CB1 receptor agonist

CB:

Cannabinoid

CN:

Cochlear nucleus

∆9-THC:

D9-tetrahydrocannabinol

DAG:

Diacylglycerol lipase

DCN:

Dorsal cochlear nucleus

FAAH:

Fatty acid amide hydrolase

GABA:

Gamma-amino butyric acid

IPSC:

Inhibitory post-synaptic currents

LTD:

Long-term depression

LTP:

Long-term potentiation

MAGL:

Monoacylglycerol lipase

NAPE-PLD:

N-arachidonoylphosphatidylethanola­mine-phospholipase-D

PEA:

N-palmitoylethanolamide

PSP:

Post-synaptic potentials

SCE:

Standard cannabis extracts

VCN:

Ventral cochlear nucleus

References

  1. Eggermont, JJ. Cortical tonotopic map reorganization and its implication for treatment of tinnitus. Acta Oto-laryngol (Stockh) 2006, 126:9–12

    Article  Google Scholar 

  2. Eggermont, JJ and Roberts, LE. The neuroscience of tinnitus. Trends Neurosci 2004, 27(11):676–682

    Article  PubMed  CAS  Google Scholar 

  3. Baguley, DM. What progress have we made with tinnitus? Acta Otolaryngol (Stock) 2006, 126:4–8

    Article  Google Scholar 

  4. Zhang, JS and Kaltenbach, JA. Increases in spontaneous activity in the dorsal cochlear nucleus of the rat following exposure to high intensity sound. Neurosci Lett 1998, 250:197–200

    Article  PubMed  CAS  Google Scholar 

  5. Kaltenbach, JA and Afman, CE. Hyperactivity in the dorsal cochlear nucleus after intense sound exposure and its resemblance to tone-evoked activity: a physiological model for tinnitus. Hear Res 2000, 140(1–2):165–172

    Article  PubMed  CAS  Google Scholar 

  6. Brozoski, TJ, Bauer, CA, and Caspary, DM. Elevated fusiform cell activity in the dorsal cochlear nucleus of chinchillas with psychophysical evidence of tinnitus. J Neurosci 2002, 22(6):2383–2390

    PubMed  CAS  Google Scholar 

  7. Zacharek, MA, Kaltenbach, JA, Mathog, TA, and Zhang, J. Effects of cochlear ablation on noise induced hyperactivity in the hamster dorsal cochlear nucleus: implications for the origin of noise induced tinnitus. Hear Res 2002, 172(1–2):137–143

    Article  PubMed  Google Scholar 

  8. Kaltenbach, JA, Zacharek, MA, Zhang, J and Frederick, S. Activity in the dorsal cochlear nucleus of hamsters previously tested for tinnitus following intense tone exposure. Neurosci Lett 2004, 355(1–2):121–125

    Article  PubMed  CAS  Google Scholar 

  9. Kaltenbach, JA and Zhang, J. Intense sound-induced plasticity in the dorsal cochlear nucleus of rats: Evidence for cholinergic receptor upregulation. Hear Res 2007, 226(1–2):232–243

    Article  PubMed  CAS  Google Scholar 

  10. Chang, H, Chen, K, Kaltenbach, JA, Zhang, J and Godfrey, DA. Effects of acoustic trauma on dorsal cochlear nucleus neuron activity in slices. Hear Res 2002, 164:59–98

    Article  PubMed  Google Scholar 

  11. Ma, WLD and Young, ED. Dorsal cochlear response properties following acoustic trauma: response maps and spontaneous activity. Hear Res 2006, 216–217:176–188

    Article  PubMed  Google Scholar 

  12. Wang J, Ding D and Salvi RJ. Functional reorganization in chinchilla inferior colliculus associated with chronic and acute cochlear damage. Hear Res 2002, 168:238–249

    Article  PubMed  Google Scholar 

  13. Basta, D and Ernst, A. Noise-induced changes of neuronal spontaneous activity in mice inferior colliculus brain slices. Neurosci Lett 2004, 368:297–302

    Article  PubMed  CAS  Google Scholar 

  14. Basta, D and Ernst, A. Effects of salicylate on spontaneous activity in inferior colliculus brain slices. Neurosci Res 2004, 50:237–243

    Article  PubMed  CAS  Google Scholar 

  15. Norena, AJ and Eggermont, JJ. Changes in spontaneous neural activity immediately after an acoustic trauma: implications for neural correlates of tinnitus. Hear Res 2003, 183:137–153

    Article  PubMed  CAS  Google Scholar 

  16. Seki, S and Eggermont, JJ. Changes in spontaneous firing rate and neural synchrony in cat primary auditory cortex after tone-induced hearing loss. Hear Res 2003, 180:28–38

    Article  PubMed  Google Scholar 

  17. Møller, AR. Similarities between severe tinnitus and chronic pain. J Am Acad Audiol 2000, 11(3):115–124

    PubMed  Google Scholar 

  18. Møller, AR. Pathophysiology of tinnitus. Otolaryngol Clin North Am 2003, 36:249–266

    Article  PubMed  Google Scholar 

  19. Simpson, JJ and Davies, WE. Recent advances in the pharmacological treatment of tinnitus. Trends Pharmacol Sci 1999, 20(1):12–18

    Article  PubMed  CAS  Google Scholar 

  20. Gananca, MM, Caovilla, HH, Gananca, FF, Gananca, CF, Munhoz, MS, da Silva, ML and Serafini, F. Clonazepam in the pharmacological treatment of vertigo and tinnitus. Int Tinnitus J 2002, 8:50–53

    PubMed  CAS  Google Scholar 

  21. Shulman A, Strashun, AM and Goldstein, BA. GABA(A)-benzodiazepine-chloride receptor-targeted therapy for tinnitus control: preliminary report. Int Tinnitus J 2002, 8:30–36

    PubMed  CAS  Google Scholar 

  22. Menkes, DB and Larson, PM. Sodium valproate for tinnitus. J Neurol Neurosurg Psychiatr 1998, 65:803

    Article  PubMed  CAS  Google Scholar 

  23. Levine, RA. Typewriter tinnitus: a carbamazepine-­responsive syndrome related to auditory nerve vascular compression. J Otorhinolaryngol Relat Spec 2006, 68:43–46

    Article  CAS  Google Scholar 

  24. Melding, PS and Goodey, RJ. The treatment of tinnitus with oral anticonvulsants. J Laryngol Otol 1979, 93(2):111–122

    Article  PubMed  CAS  Google Scholar 

  25. Sanchez, TG, Balbani, AP, Bittar, RS, Bento, RF and Camara, J. Lidocaine test in patients with tinnitus: rationale of accomplishment and relation to the treatment with carbamazepine Auris, Nasus. Larynx 1999, 26:411–417

    Article  CAS  Google Scholar 

  26. Hulshof, JH and Vermeij. The value of carbamazepine in the treatment of tinnitus. J Otorhinolaryngol Related Spec 1985, 47:262–266

    Google Scholar 

  27. Bauer, CA and Brozoski, TJ. Gabapentin. Prog Brain Res 2007, 166:287–301

    Article  PubMed  CAS  Google Scholar 

  28. Zapp, JJ. Gabapentin for the treatment of tinnitus: a case report. Ear Nose Throat J 2001, 80:114–116

    PubMed  CAS  Google Scholar 

  29. Bauer, CA and Brozoski, TJ. Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope 2006, 116:675–681

    Article  PubMed  CAS  Google Scholar 

  30. Witsell, DL, Hannley, MT, Stinnet, S and Tucci, DL. Treatment of tinnitus with gabapentin: a pilot study. Otol Neurol 2007, 28(1):11–15

    Article  Google Scholar 

  31. Piccirillo, JF, Finnell, J, Vlahiotis, A, Chole RA and Spitznagel, E Jr. Relief of idiopathic subjective tinnitus: is gabapentin effective? Arch Otolaryngol Head Neck Surg 2007, 133:390–397

    Article  PubMed  Google Scholar 

  32. Iversen, L. Cannabis and the brain. Brain 2003, 126:1252–1270

    Article  PubMed  Google Scholar 

  33. Howlett, AC, Breivogel, CS and Childers, CR. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 2004, 47:345–358

    Article  PubMed  CAS  Google Scholar 

  34. De Petrocellis, L, Cascio, MG and Di Marzo, V. The endocannabinoid system: A general review and latest additions. Br J Pharmacol 2004, 141:765–774

    Article  PubMed  Google Scholar 

  35. Piomelli, D, Giuffrida, A, Calignano, A and Rodriguez de Fonseca, F. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 2000, 21:218–224

    Article  PubMed  CAS  Google Scholar 

  36. Gordon, E and Devinsky, O. Alcohol and marijuana: Effects on epilepsy and use by patients with epilepsy. Epilepsia 2001, 42:1266–1272

    Article  PubMed  CAS  Google Scholar 

  37. Lutz, B. On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem Pharmacol 2004, 68:1691–1698

    Article  PubMed  CAS  Google Scholar 

  38. Zagnoni, PG and Albano, C. Psychostimulants and epilepsy. Epilepsia 2002, 43(Suppl 2):28–31

    Google Scholar 

  39. Lorenz, R. On the application of cannabis in paediatrics and epileptology. Neuro Endocrinol Lett 2004, 25:40–44

    PubMed  CAS  Google Scholar 

  40. Alger, BE. Retrograde signalling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 2002, 68:247–286

    Article  PubMed  CAS  Google Scholar 

  41. Kreitzer, AC and Regehr, WG. Retrograde signalling by endocannabinoids. Curr Opin Neurobiol 2002, 12:324–330

    Article  PubMed  CAS  Google Scholar 

  42. Wallace, MJ, Balir, RE, Falenski, KW, Martin, BR and Delorenzo, RJ. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 2003, 307:129–137

    Article  PubMed  CAS  Google Scholar 

  43. Shafaroodi, H, Samini, M, Moezi, L, Homayoun, H, Sadeghipour, H, Tavakoli, S, Hajrasouliha, AR and Dehpour, AR. The interaction of cannabinoids and opioids on ­pentylenetetrazole-induced seizure threshold in mice. Neuropharmacology 2004, 47:390–400

    Article  PubMed  CAS  Google Scholar 

  44. Hoffman, AF and Lupica, CR. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J Neurosci 2000, 20:2470–2479

    PubMed  CAS  Google Scholar 

  45. Nakatsuka, T, Chen, H-X, Roper, SN and Gu, JG. Cannabinoid receptor-1 activation suppresses inhibitory synaptic activity in human dentate gyrus. Neuropharmacology 2003, 45:116–121

    Article  PubMed  CAS  Google Scholar 

  46. Whalley BJ, Wilkinson JD, Williamson, EM and Constanti, A. A novel component of cannabis extract potentiates excitatory synaptic transmission in rat olfactory cortex in vitro. Neurosci Lett 2004, 365:58–63

    Article  PubMed  CAS  Google Scholar 

  47. Wilkinson, JD, Whalley, BJ, Baker, D, Pryce, G, Constanti, A, Gibbons, S and Williamson, EM. Medicinal cannabis: Is delta-9-tetrahydrocannabinol necessary for all its effects? J Pharm Pharmacol 2003, 55:1687–1694

    Article  PubMed  CAS  Google Scholar 

  48. Marsicano, G, Goodenough, S, Monory, K, Hermann, H, Eder, M, Cannich, A, Azad, SC, Cascio, MG, Gutierrez, SO, van der Stelt, M, Lopez-Rodriguez, ML et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 2003, 302:84–88

    Article  PubMed  CAS  Google Scholar 

  49. Mechoulam, R and Lichtmanm AH. Stout guards of the central nervous system. Science 2003, 302:65–67

    Article  PubMed  CAS  Google Scholar 

  50. Ludanyi, A, Eross, L, Czirjak, S, Vajda, J, Halasz, P, Watanabe, M, Palkovits, M, Magloczky, Z, Freund, TF and Katona, I. Down regulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J Neurosci 2008, 28:2976–2990

    Article  PubMed  CAS  Google Scholar 

  51. Wallace, MJ, Martin, BR and Delorenzo, RJ. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 2002, 452:295–301

    Article  PubMed  CAS  Google Scholar 

  52. Ameri, A, Wilhelm, A and Simmet, T. Effects of the endogenous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br J Pharmacol 1999, 126:1831–1839

    Article  PubMed  CAS  Google Scholar 

  53. Lambert, DM, Vandervoorde, S, Diependale, G, Govaerts, SJ and Robert, AR. Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice. Epilepsia 2001, 42:321–327

    Article  PubMed  CAS  Google Scholar 

  54. Sheerin, AH, Zhang, X, Saucier, DM and Corcoran, ME. Selective antiepileptic effects of N-palmitoylethanolamide, a putative endocannabinoid. Epilepsia 2004, 45:1184–1188

    Article  PubMed  CAS  Google Scholar 

  55. Herkenkam, M, Lynn, AB, Johnson, MR, Melvin, LS, de Costa, BR and Rice, KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991, 11:563–583

    Google Scholar 

  56. Brievogel, CS, Sim, LJ and Childers, SR. Regional differences in cannabinoid receptor/G protein coupling in rat brain. J Pharmacol Exp Ther 1997, 282:1632–1642

    Google Scholar 

  57. Zheng, Y, Baek, J-H, Smith, PF and Darlington, CL. Cannabinoid receptor down-regulation in the ventral cochlear nucleus in an animal model of tinnitus. Hear Res 2007, 228:105–111

    Article  PubMed  CAS  Google Scholar 

  58. Tzounopoulos, T, Rubio, ME, Keen, JE, and Trussell, LO. Coactivation of pre- and post-synaptic signaling mechanisms determines cell-specific spike-timing-dependent plasticity. Neuron 2007, 54:291–301

    Article  PubMed  CAS  Google Scholar 

  59. Ashton, JC, Zheng, Y, Liu, P, Darlington, CL and Smith, PF. Immunohistochemical characterization and localization of cannabinoid CB1 receptor protein in the rat vestibular nucleus complex and effects of unilateral vestibular deafferentation. Brain Res 2004, 1021:266–273

    Article  Google Scholar 

  60. Zhao, Y, Rubio, ME and Tzounopoulos, T. Distinct functional and anatomical architecture of the endocannabinoid system in the auditory brainstem. J Neurophysiol 2009, 101:2434–2446

    Article  PubMed  CAS  Google Scholar 

  61. Baek, J-H, Zheng, Y, Darlington, CL and Smith, PF. Cannabinoid CB2 receptor expression in the vestibular and cochlear nuclei. Acta Otolaryngol (Stockh) 2008, 128(9):961–967

    Article  CAS  Google Scholar 

  62. Jastreboff, PJ, Brennan, JF, Coleman, JK, and Sasaki, CT. Phantom auditory sensation in rats: an animal model of tinnitus. Behav Neurosci 1988, 102(6):811–822

    Article  PubMed  CAS  Google Scholar 

  63. Raby, WN, Modica, PA, Wolintz, RJ, and Murtaugh, K. Dronabinol reduces signs and symptoms of idiopathic intracranial hypertension: a case report. J Ocul Pharmacol Ther 2006, 22(1):68–75

    Article  PubMed  CAS  Google Scholar 

  64. Smith, PF. Symptomatic treatment of multiple sclerosis using cannabinoids: Recent advances. Expert Rev Neurother 2007, 7(9):1157–1163

    Article  PubMed  CAS  Google Scholar 

  65. Wade, DT, Makela, PM, House, H, Bateman, C and Robson. Long-term use of a cannabis based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Multiple Sclerosis 2006, 12:639–645

    Google Scholar 

  66. Smith, F and Darlington, CL. Drug treatments for subjective tinnitus: serendipitous discovery versus rational drug design. Curr Opin Invest Drug 2005, 6(7):712–716

    CAS  Google Scholar 

Download references

Acknowledgements

This research was generously supported by the Jean Cathie Estate.

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, School of Medical Sciences, University of Otago Medical School, Dunedin, New Zealand

    Paul F. Smith

Authors
  1. Paul F. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul F. Smith .

Editor information

Editors and Affiliations

  1. School of Behavioral and Brain Sciences, The University of Texas at Dallas, Richardson, Texas, USAUSA

    Aage R. Møller

  2. Department of Psychiatry Psychotherapy and Psychosomatics, University of Regensburg, Regensburg, Germany

    Berthold Langguth

  3. BRAI2N/TRI Tinnitus Clinic and Department of Neurosurgery, University Hospital Antwerp, Wilrijkstraat 10, 2650, Edegem, Belgium

    Dirk De Ridder

  4. Department of Otorhinolaryngology, University of Regensburg, Regensburg, Germany

    Tobias Kleinjung

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Smith, P.F. (2011). The Endocannabinoid System in the Cochlear Nucleus and Its Implications for Tinnitus Treatment. In: Møller, A.R., Langguth, B., De Ridder, D., Kleinjung, T. (eds) Textbook of Tinnitus. Springer, New York, NY. https://doi.org/10.1007/978-1-60761-145-5_79

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-145-5_79

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-60761-144-8

  • Online ISBN: 978-1-60761-145-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation